摘要:
1-carba-(dethia)-cephalosporin derivatives of the general formula I wherein
R 1 is hydrogen, optionally fluoro substituted lower alkyl, aralkyl, cycloalkyl, -COR 4 or -C(R 5 R 6 )CO 2 R 7 -C(R 5 R 6 )CONHR 7 ; where R 5 and R 6 are each independently hydrogen or lower alkyl, or R 5 and R 6 taken together form a cycloalkyl group; R 4 is hydrogen or lower alkyl and R 7 is hydrogen, lower alkyl, lower alkenyl or a carboxylic acid protecting group; R 2 is hydrogen, hydroxy, lower alkyl-Q m , cycloalkyl, lower alkoxy, lower alkenyl, cycloalkenyl, lower alkynyl, aralkyl-Q m , aryl-Q m , aryloxy, aralkoxy, a heterocyclic ring or heterocyclyl lower alkyl, the lower alkyl, cycloalkyl, lower alkoxy, lower alkenyl, cycloalkenyl, lower alkynyl, aralkyl, aryl, aryloxy, aralkoxy and the heterocyclic ring being unsubstituted or substituted with at least one group selected from carboxy, amino, nitro, cyano, optionally fluoro substituted lower alkyl, lower alkoxy, hydroxy, halogen, -COR 6 , -C(R 5 R 6 )CO 2 R 7 , -C(R 5 R 6 )CONR 5 R 8 , -CONR 5 R 6 , -N(R 6 )COOR 10 , R 6 OCO- or R 6 COO- where R 5 and R 6 are hydrogen or lower alkyl; R 7 is hydrogen, lower alkyl, lower alkenyl or a carboxylic acid protecting group; R 8 is hydrogen, lower alkyl or optionally substituted phenyl; R 10 is lower alkyl, lower alkenyl or a carboxylic acid protecting group; Q is -CHR-, -CO- or -SO 2 -; R is hydrogen or lower alkyl R 3 is hydroxy, lower-alkoxy, or -O - , when R 2 has a positive charge, or -OM and M represents an alkali metal; m is 0 or 1; n is 0, 1 or 2; X is CH or N as well as readily hydrolysable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts.
摘要:
The invention is directed to the crystalline isopropyl alcohol solvate of loracarbef, and also is directed to a process for the preparation of the crystalline monohydrate form of the compound of formula (I)
which includes exposing the crystalline isopropyl solvate form of the compound of formula (I) to a temperature of between about 50° and 90°C and a relative humidity of between about 60 to about 100%.
摘要:
4-substituted azetidinones having the formulae I and II:
with R¹, R², R³, R⁴, R⁵ and X defined hereafter, which are intermediates for the preparation of carbapenem and carbacephem antibacterials and processes for producing such antibacterials through the utilization of an acid mediated ring closure reaction. R¹is hydrogen, hydroxy (lower) alkyl or protected hydroxy (lower) alkyl; R²is selected from the group consisting of hydrogen and (C₁-C₆) alkyl; R³is hydrogen, or an organic group; R⁴is hydrogen or a suitable removable protecting group for an amide nitrogen; R⁵is hydrogen or a suitable removable protecting group for a carboxylic acid; Xis oxygen, sulfur, a moiety of the formula NR⁶.
摘要:
A process is provided for producing 7-protected-amino-4-protected carboxy-3-halo-1-carbacephalosporins which includes the steps of mixing the hydrochloride salt of the carbacephalosporin with a polar organic aprotic solvent having a dielectric constant of at least about 20 and a base selected from a group consisting of 5- or 6-membered tertiary cyclic amine containing 0-1 oxygen atoms, and dimethylbenzamine to form the free amine of a carbacephalosporin and thereafter without isolating the free amine mixing it with an acylating agent to result in the doubly blocked carbacephalosporin.
摘要:
The invention provides a process for preparing 7-protected amino-4-protected carboxy-1-carbacephalosporins which includes subjecting a 3-protected-amino-4-(1-propylene oxide)-methyl(protected carboxy)-azetidin-2-one to a strong base to form a 2-hydroxycepham and thereafter dehydrating the 2-hydroxycepham to form the desired 1-carbacephalosporin. Also included in the invention are novel intermediates.
摘要:
A process for producing beta-lactam derivatives, which comprises reacting a beta-lactam derivative wherein the carboxyl group is protected and which is represented by the general formula: A-COO-X (wherein A represents a beta-lactam derivative residue, and X represents a benzyl group having an electron-donating group in the phenyl group, a diphenylmethyl group optionally having an electron-donating group in the phenyl group, or a tert-butyl group) with a phenol to obtain a beta-lactam derivative represented by the general formula: A-COOH (wherein A is the same as defined above).
摘要:
Various 3-substituted 1-carba(1-dethia)-3-cephems, useful as antibacterial agents are provided. Also provided are pharmaceutical compositions comprising same and methods for treating bacterial infections in man and other animals. An antibacterial compound of the formula
wherein R is hydrogen, C₁-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C₃-C₆ cycloalkyl, or C₁-C₆ haloalkyl; A and A′ are independently hydrogen, C₁-C₆ alkyl, nitro, amino, a 5-6 membered organic heterocycle containing 1, 2 or 3 hetero atoms selected from nitrogen or sulfur, C₁-C₆ alkoxy or phenyl; or A and A′ taken together from a group of the formulae
wherein X is hydrogen, halo, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ alkoxycarbonyl, amino, nitro, or carboxy; and Y is nitrogen or carbon; or a pharmaceutically acceptable salt thereof.
X is sulfur or CH2; R 1 is hydrogen, hydroxy, amino, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, phenyl optionally substituted with one to three C 1-6 alkyl, C 1-6 alkyloxy or hydroxy, C 1-6 alkylthio, phenylthio optionally substituted with one to three C 1-6 alkyl or C 1-6 alkyloxy on the phenyl ring, phenylmethyloxy optionally substituted with one to three C 1-6 alkyl or C 1-6 alkyloxy on the phenyl ring, 1-morpholino, C 1-6 alkyloxy, C 2-6 alkenylmethyloxy, C 3-6 alkynylmethyloxy, C 1-6 alkylamino, C 1-6 dialkylamino or a radical selected from the group consisting of and
in which n is 0 to 3, R 5 is C 1-6 alkyl or hydrogen, and R 3 and R 4 are independently C 1-6 alkyl ; R 2 is hydrogen, a conventional amino protecting group or an acyl group ; R° is hydrogen or a conventional carboxy protecting group, or -CO Z R° taken together forms a physiologically hydrolyzable ester; or pharmaceutically acceptable salts or solvates thereof.
摘要翻译:式I化合物其中X是硫或CH2; R 1是氢,羟基,氨基,C 1-6烷基,C 2-6烯基,C 2-6炔基,任选地被一至三个C 1-6烷基,C 1-6烷氧基或羟基,C 1-6烷硫基, 任选被苯基环上一至三个C 1-6烷基或C 1-6烷氧基取代的苯硫基,苯基环上任选被一至三个C 1-6烷基或C 1-6烷氧基取代的苯基甲氧基,1-吗啉代,C 1-6烷氧基 ,C 2-6烯基甲氧基,C 3-6炔基甲氧基,C 1-6烷基氨基,C 1-6二烷基氨基或选自下组的基团,其中n为0至3,R 5为C 1-6烷基或 氢,R 3和R 4独立地是C 1-6烷基; R 2是氢,常规的氨基保护基或酰基; R DEG是氢或常规的羧基保护基,或-CO 2 R 2一起形成生理上可水解的酯; 或其药学上可接受的盐或溶剂化物。 婷
摘要:
7 α-formamido cephalosporin derivatives having a 3[N-(optionally substituted)aminothiopyridinium thiomethyl] substituent have anti-bacterial activity and are of use in anti-bacterial therapy. Processes for the preparation thereof and intermediates for use in these processes are also disclosed.